A new Israeli study has found that the proportion of women who reported side effects after receiving their first, second, or third dose of the Pfizer vaccination is 1.9 times that among men. Prof. Cyrille Cohen, head of the Immunotherapy Laboratory at Bar-Ilan University, was interviewed about the research. Read More.
